Fluorescence-Guided Surgery: Clinical Trials

4 trials of Fluorescence-Guided Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 recruiting, 1 completed. 2 Phase 2, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Recruiting 2
Not applicable1Recruiting 1
Phase 11Recruiting 1

Follow Fluorescence-Guided Surgery: new trials by email Literature Review of Fluorescence-Guided Surgery trials Research Report on Fluorescence-Guided Surgery

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Fluorescence-Guided Surgical Resection for Reducing Unexpected Positive Margins in Patients With Sarcoma, SarcoSIGHT Trial
Electronic Health Record Review, Fluorescence Imaging, Fluorescence-Guided Surgery - High Grade Sarcoma, Sarcoma
Phase 2RecruitingCity of Hope Medical Center222026-08-142026-10-16
Feasibility of Aspirate Tissue Monitoring in Neuro-oncological Surgery
Aspirate tissue monitoring, Fluorescence-guided surgery - High Grade Gliomas
Not applicableRecruitingKuopio University Hospital502024-09-302024-12-18
Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
Aminolevulinic Acid, Biospecimen Collection, Computed Tomography - Locally Advanced Colorectal Carcinoma, Recurrent Colorectal Carcinoma
Phase 1 / Phase 2RecruitingRoswell Park Cancer Institute212024-07-302026-10-15
5-Aminolevulinic Acid (5-ALA) to Enhance Visualization of Malignant Tumor
GliolanĀ®, Fluorescence-Guided Surgery - Malignant Gliomas
CompletedConstantinos Hadjipanayis692016-05-012019-02-25

Conditions studied

Glioma (2)  ·  Colorectal Neoplasms (1)  ·  Neoplasms (1)  ·  Sarcoma (1)

Sponsors

City of Hope Medical Center (1)  ·  Constantinos Hadjipanayis (1)  ·  Kuopio University Hospital (1)  ·  Roswell Park Cancer Institute (1)

Countries

United States (3)  ·  Finland (1)  ·  Norway (1)

Top investigators

Anthony S Dakwar (1)  ·  Antti-Pekka Elomaa, Docent (1)  ·  Bob Carter, MD, PhD (1)  ·  Einar Vik-Mo, Professor (1)  ·  Joonas Haapasalo, Docent (1)  ·  Thinzar Lwin (1)

NIH funding

P30CA033572 (1), UL1TR001412 (1)